MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 218 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | 0.0% | 17 | -19.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | – | 21 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q3 2019 | $21,000 | -30.0% | 2,200 | +3.9% | 0.00% | 0.0% |
| Q3 2017 | $30,000 | -9.1% | 2,117 | +0.7% | 0.00% | 0.0% |
| Q2 2017 | $33,000 | +13.8% | 2,102 | +0.7% | 0.00% | 0.0% |
| Q1 2017 | $29,000 | +123.1% | 2,087 | +194.4% | 0.00% | 0.0% |
| Q4 2016 | $13,000 | -40.9% | 709 | -39.2% | 0.00% | 0.0% |
| Q3 2016 | $22,000 | -4.3% | 1,166 | -1.9% | 0.00% | 0.0% |
| Q2 2016 | $23,000 | +27.8% | 1,189 | +33.6% | 0.00% | 0.0% |
| Q4 2015 | $18,000 | – | 890 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |